Content area
Abstract
Following infection or vaccination, activated B cells at extrafollicular sites or within germinal centers (GCs) undergo vigorous clonal proliferation. Proliferating lymphocytes have been shown to undertake lactate dehydrogenase A (LDHA)-dependent aerobic glycolysis; however, the specific role of this metabolic pathway in a B cell transitioning from a naïve to a highly proliferative, activated state remains poorly defined. Here, we deleted LDHA in a stage-specific and cell-specific manner. We find that ablation of LDHA in a naïve B cell did not profoundly affect its ability to undergo a bacterial lipopolysaccharide-induced extrafollicular B cell response. On the other hand, LDHA-deleted naïve B cells had a severe defect in their capacities to form GCs and mount GC-dependent antibody responses. In addition, loss of LDHA in T cells severely compromised B cell-dependent immune responses. Strikingly, when LDHA was deleted in activated, as opposed to naïve, B cells, there were only minimal effects on the GC reaction and in the generation of high-affinity antibodies. These findings strongly suggest that naïve and activated B cells have distinct metabolic requirements that are further regulated by niche and cellular interactions.
Sharma et al. identify an early metabolic checkpoint dependent upon lactate dehydrogenase for newly activated B cells to enter germinal centers.
Details
; Chowdhury, Priyanka 3 ; Fernandez, Keith Conrad 3 ; Kim, Youngjun 3 ; Cols, Montserrat 1 ; Alread, William 1 ; Yen, Wei-Feng 1
; Hu, Wei 1
; Wang, Zhong-Min 2
; Violante, Sara 4 ; Chaligné, Ronan 5 ; Li, Ming O. 6
; Cross, Justin R. 4
; Chaudhuri, Jayanta 6
1 Memorial Sloan Kettering Cancer Center, Immunology Program, Sloan Kettering Institute, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
2 Gerstner Sloan Kettering Graduate School of Biomedical Sciences, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
3 Weill Cornell Graduate School of Medical Sciences, Immunology and Microbial Pathogenesis Program, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
4 Memorial Sloan Kettering Cancer Center, Donald B. and Catherine C. Marron Cancer Metabolism Center, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
5 Memorial Sloan Kettering Cancer Center, Computational and Systems Biology Program, Sloan Kettering Institute, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
6 Memorial Sloan Kettering Cancer Center, Immunology Program, Sloan Kettering Institute, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); Gerstner Sloan Kettering Graduate School of Biomedical Sciences, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); Weill Cornell Graduate School of Medical Sciences, Immunology and Microbial Pathogenesis Program, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)





